Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Characterising skeletal muscle haemoglobin saturation during exercise using near-infrared spectroscopy in chronic kidney disease.

Wilkinson TJ, White AEM, Nixon DGD, Gould DW, Watson EL, Smith AC.

Clin Exp Nephrol. 2018 Jun 30. doi: 10.1007/s10157-018-1612-0. [Epub ahead of print]

PMID:
29961156
2.

Quality over quantity? Association of skeletal muscle myosteatosis and myofibrosis on physical function in chronic kidney disease.

Wilkinson TJ, Gould DW, Nixon DGD, Watson EL, Smith AC.

Nephrol Dial Transplant. 2018 Jun 22. doi: 10.1093/ndt/gfy139. [Epub ahead of print]

PMID:
29939315
3.

Anthropometry-based Equations to Estimate Body Composition: A Suitable Alternative in Renal Transplant Recipients and Patients With Nondialysis Dependent Kidney Disease?

Wilkinson TJ, Richler-Potts D, Nixon DGD, Neale J, Smith AC.

J Ren Nutr. 2018 May 24. pii: S1051-2276(18)30081-5. doi: 10.1053/j.jrn.2018.04.003. [Epub ahead of print]

PMID:
29804641
4.

A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB.

Ourahmane A, Sauer A, Nixon DE, Murphy C, Mondello M, Douglass Chiu E, Siegmund S, Wang JB, McVoy MA.

Antiviral Res. 2018 Jun;154:44-50. doi: 10.1016/j.antiviral.2018.04.006. Epub 2018 Apr 9.

PMID:
29649495
5.

Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.

Nixon DW.

Brain Sci. 2018 Mar 24;8(4). pii: E53. doi: 10.3390/brainsci8040053. Review.

6.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015.

Dwyer DE, Lynfield R, Losso MH, Davey RT, Cozzi-Lepri A, Wentworth D, Uyeki TM, Gordin F, Angus B, Qvist T, Emery S, Lundgren J, Neaton JD; INSIGHT Influenza Study Group .

Open Forum Infect Dis. 2017 Oct 7;4(4):ofx212. doi: 10.1093/ofid/ofx212. eCollection 2017 Fall.

7.

Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.

Hall CE, Koparde VN, Jameson-Lee M, Elnasseh AG, Scalora AF, Kobulnicky DJ, Serrano MG, Roberts CH, Buck GA, Neale MC, Nixon DE, Toor AA.

PLoS One. 2017 Aug 11;12(8):e0178763. doi: 10.1371/journal.pone.0178763. eCollection 2017.

8.

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).

Nixon DE, Bosch RJ, Chan ES, Funderburg NT, Hodder S, Lake JE, Lederman MM, Klingman KL, Aberg JA; AIDS Clinical Trials Group Study A5275 Team.

J Clin Lipidol. 2017 Jan - Feb;11(1):61-69. doi: 10.1016/j.jacl.2016.09.017. Epub 2016 Oct 5.

9.

The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.

Nixon DW.

Curr Alzheimer Res. 2017;14(8):883-893. doi: 10.2174/1567205014666170216152905. Review.

PMID:
28215174
10.

Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.

Kunisaki KM, Niewoehner DE, Collins G, Aagaard B, Atako NB, Bakowska E, Clarke A, Corbelli GM, Ekong E, Emery S, Finley EB, Florence E, Infante RM, Kityo CM, Madero JS, Nixon DE, Tedaldi E, Vestbo J, Wood R, Connett JE; INSIGHT START Pulmonary Substudy Group.

Lancet Respir Med. 2016 Dec;4(12):980-989. doi: 10.1016/S2213-2600(16)30319-8. Epub 2016 Oct 20.

11.

A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Adler SP, Manganello AM, Lee R, McVoy MA, Nixon DE, Plotkin S, Mocarski E, Cox JH, Fast PE, Nesterenko PA, Murray SE, Hill AB, Kemble G.

J Infect Dis. 2016 Nov 1;214(9):1341-1348. Epub 2016 Aug 11.

12.

Do stiffness and asymmetries predict change of direction performance?

Maloney SJ, Richards J, Nixon DG, Harvey LJ, Fletcher IM.

J Sports Sci. 2017 Mar;35(6):547-556. doi: 10.1080/02640414.2016.1179775. Epub 2016 Apr 30.

PMID:
27133586
13.

The use of unboosted darunavir in the setting of ritonavir intolerance: three case reports.

Smith K, Gomes D, Nixon D, Fulco PP.

Int J Clin Pharmacol Ther. 2016 Jan;54(1):52-7. doi: 10.5414/CP202476.

PMID:
26636419
14.

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.

Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS; AIDS Clinical Trials Group (ACTG) A5257 Team.

Clin Infect Dis. 2015 Jun 15;60(12):1842-51. doi: 10.1093/cid/civ193. Epub 2015 Mar 12.

15.

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD.

HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available.

16.

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.

Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD; INSIGHT SMART Study Group.

PLoS One. 2012;7(9):e44454. doi: 10.1371/journal.pone.0044454. Epub 2012 Sep 10.

17.

HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.

Baker JV, Neuhaus J, Duprez D, Freiberg M, Bernardino JI, Badley AD, Nixon DE, Lundgren JD, Tracy RP, Neaton JD; INSIGHT SMART Study Group.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):128-34. doi: 10.1097/QAI.0b013e318252f99f.

18.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, Neaton JD, Brenchley JM, Deeks SG, Sereti I, Douek DC; INSIGHT SMART Study Group.

J Infect Dis. 2011 Mar 15;203(6):780-90. doi: 10.1093/infdis/jiq118. Epub 2011 Jan 20.

19.

Biomarkers of immune dysfunction in HIV.

Nixon DE, Landay AL.

Curr Opin HIV AIDS. 2010 Nov;5(6):498-503. doi: 10.1097/COH.0b013e32833ed6f4. Review.

20.

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.

Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD; INSIGHT SMART Study Group.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):36-43. doi: 10.1097/QAI.0b013e3181f7f61a.

Supplemental Content

Loading ...
Support Center